UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy Journal article
Lei, Josh Haipeng, Lee, Mi Hye, Miao, Kai, Huang, Zebin, Yao, Zhicheng, Zhang, Aiping, Xu, Jun, Zhao, Ming, Huang, Zenan, Zhang, Xin, Chen, Si, Jiaying, N. G., Feng, Yuzhao, Xing, Fuqiang, Chen, Ping, Sun, Heng, Chen, Qiang, Xiang, Tingxiu, Chen, Lin, Xu, Xiaoling, Deng, Chu Xia. Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy[J]. Advanced Science, 2021, 8(21), 2100974.
Authors:  Lei, Josh Haipeng;  Lee, Mi Hye;  Miao, Kai;  Huang, Zebin;  Yao, Zhicheng; et al.
Favorite | TC[WOS]:23 TC[Scopus]:17  IF:14.3/16.3 | Submit date:2021/11/30
Brca1  Breast Cancer  Fgfr2 Inhibitor  Fgfr2-s252w  Tumor Slice Culture  
Fibroblast growth factor receptor 2 signaling in breast cancer Journal article
Lei,Haipeng, Deng,Chu Xia. Fibroblast growth factor receptor 2 signaling in breast cancer[J]. International Journal of Biological Sciences, 2017, 13(9), 1163-1171.
Authors:  Lei,Haipeng;  Deng,Chu Xia
Favorite | TC[WOS]:39 TC[Scopus]:39  IF:8.2/8.3 | Submit date:2020/09/16
Breast Cancer  Fgfr2  Inhibitor  Mutation  Polymorphism  
Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer Journal article
Lei, Haipeng, Deng, Chu-Xia. Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13(9), 1163-1171.
Authors:  Lei, Haipeng;  Deng, Chu-Xia
Favorite | TC[WOS]:39 TC[Scopus]:39  IF:8.2/8.3 | Submit date:2018/10/30
Breast Cancer  Fgfr2  Mutation  Polymorphism  Inhibitor